Beckman Coulter, Inc., a leading name in the life sciences and diagnostics industry, is headquartered in the United States. Founded in 1935, the company has established itself as a pioneer in laboratory instrumentation and reagents, focusing on areas such as clinical diagnostics and research. With a strong presence in North America, Europe, and Asia, Beckman Coulter is renowned for its innovative solutions that enhance laboratory efficiency and accuracy. The company’s core products include advanced analyzers and diagnostic systems, which are distinguished by their precision and reliability. Beckman Coulter's commitment to quality has positioned it as a trusted partner in healthcare, contributing to significant advancements in patient care. Notable achievements include numerous awards for innovation and excellence, solidifying its status as a market leader in the diagnostics sector.
How does Beckman Coulter, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Beckman Coulter, Inc.'s score of 51 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Beckman Coulter, Inc., headquartered in the US, has set ambitious climate commitments despite not having specific carbon emissions data available for the most recent year. The company is part of a corporate family that includes Danaher Corporation, which influences its sustainability initiatives. Beckman Coulter has committed to reducing its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2023 as the baseline year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. The company also aims to measure and reduce its Scope 3 emissions, which encompass indirect emissions from its value chain. The reduction targets reflect a proactive approach to climate action, demonstrating Beckman Coulter's commitment to sustainability and environmental responsibility within the healthcare and laboratory equipment sector.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Scope 1 | 138,341,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 219,166,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beckman Coulter, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.